1-9 of 9
Anton Borg
Close
Sort by
Journal Articles

12-Month Full Donor Chimerism Is Associated with Low-Grade Acute Graft Versus Host Disease (aGVHD) and Predicts Superior Outcomes in Reduced Intensity (RIC) Alemtuzumab-Based Transplants for MDS and AML

Alex George Kanellopoulos, MD, Shankaranarayana Paneesha, MD, Evgenia Xenou, MD, Iman Qureshi, MBBS, MRCP, Dewi Tomos Eden, MRCP,MB,FRCPath, David John Sutton, MBBChir, MRCP, BSc, Rebecca Pryor, MB, MRCP, Lorna Cain, Carolina Arbuthnot, Richard Lovell, Anton Borg, MDFRCP,FRCPath, Katie Randall, MB, FRCPath, Kathy Holder, Julie Suhr, Lynda Baker, Lynn Ryan, Maria Kaparou, Bhuvan Kishore, MBBS, MRCP, FRCPath, Emmanouil Nikolousis, PhD MBBS, FRCPath, MBA
Journal: Blood
Blood (2016) 128 (22): 5764.
https://doi.org/10.1182/blood.V128.22.5764.5764
Published: 2016
Journal Articles

Acute Myeloid Leukemia: Low Peripheral Blast Count May Predict Better Outcome with Best Supportive Care Than with Intensive Chemotherapy in Older Patients

Duncan J Murray, MA MRCP, Jhansi Muddana, MD MRCP FRCPath, Anton Borg, MD, FRCP, FRCPath, Beth D Harrison, MA DM FRCP FRCPath
Journal: Blood
Blood (2012) 120 (21): 3550.
https://doi.org/10.1182/blood.V120.21.3550.3550
Published: 2012
Journal Articles

Elevated D-Dimer Level Is a Predictor of Poor Survival Even in Patients without Venous Thromboembolism (VTE).

S. Bacchu, Shankaranarayana Paneesha, K. French, E. Cheyne, Anton Borg, P. Rose
Journal: Blood
Blood (2006) 108 (11): 4020.
https://doi.org/10.1182/blood.V108.11.4020.4020
Published: 2006
Journal Articles

Bone Marrow Fibrosis Is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma.

Shankaranarayana Paneesha, MD, MRCP, MRCPath, Raj Pol, N. Chachlani, Guy Pratt, Peter Rose, Anton Borg
Journal: Blood
Blood (2006) 108 (11): 5059.
https://doi.org/10.1182/blood.V108.11.5059.5059
Published: 2006
Journal Articles

Upregulation of MMP-2 & 9 by Co-Culture of Human Myeloma Cell Lines and Endothelial Cells May Be Responsible for Protection Against Cytotoxic Drugs.

Shankaranarayana Paneesha, MD, MRCP, MRCPath, Raghu Adya, Hemali Khanji, Ed Leung, C. Vijayasekar, Guy Pratt, Anton Borg, Peter Rose, Alan Morris
Journal: Blood
Blood (2006) 108 (11): 5080.
https://doi.org/10.1182/blood.V108.11.5080.5080
Published: 2006
Journal Articles

A Predictive Model To Identify Patients with Venous Thromboembolism (VTE) at Minimal Risk of Malignancy.

Shankaranarayana Paneesha, MD, MRCP, MRCPath, W. Zhang, N. Parsons, K. French, E. Cheyne, S. Bacchu, Anton Borg, P. Rose
Journal: Blood
Blood (2006) 108 (11): 1500.
https://doi.org/10.1182/blood.V108.11.1500.1500
Published: 2006
Journal Articles

Bone Marrow Fibrosis Is a Not Predictor of Overall Survival in Patients with Myeloma.

P. Roberts, S. Paneesha, H. Freeman, G. Pratt, N. Chachalani, P. Rose, Anton Borg
Journal: Blood
Blood (2005) 106 (11): 5091.
https://doi.org/10.1182/blood.V106.11.5091.5091
Published: 2005
Journal Articles

Cycloxygenase-2 (COX-2) Expression Is More in Clonal Plasma Cells.

S. Paneesha, E. Leung, Anton Borg, Peter Rose, Alan G. Morris
Journal: Blood
Blood (2005) 106 (11): 5103.
https://doi.org/10.1182/blood.V106.11.5103.5103
Published: 2005
Journal Articles

High D-Dimer Levels at Presentation in Patients with Venous Thrombosis Is a Marker of Poor Overall and Event Free Survival.

Shankaranarayana Paneesha, MRCP, MRCPath, E. Cheyne, K. French, J. Motwani, J. Delgado, Anton Borg, Peter Rose
Journal: Blood
Blood (2005) 106 (11): 1625.
https://doi.org/10.1182/blood.V106.11.1625.1625
Published: 2005